Device
Polyglucosamine
Polyglucosamine is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
not_yet_recruiting133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction)
NCT06910111
completednot_applicable
Efficacy of Polyglucosamine for Weight Loss
NCT02410785
completednot_applicable
RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity
NCT02529631
Clinical Trials (3)
Showing 3 of 3 trials
NCT06910111Not Applicable
CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction)
NCT02410785Not Applicable
Efficacy of Polyglucosamine for Weight Loss
NCT02529631Not Applicable
RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3